About Us

Built at the intersection of science and medicine.

InsightRX develops precision medicine software that helps clinical pharmacists dose smarter, move faster, and drive measurably better patient outcomes, all at health system scale.

A science-first company advancing better patient outcomes.

Founded in 2015 by pharmacometricians, InsightRX began with a single conviction: that every patient deserves a dose optimized for them specifically. A decade later, that conviction drives everything we build, from our MIPD platform trusted in hospitals nationwide, to the AI-powered tools redefining what clinical decision support can be.

Our team is led by scientists, clinicians, and engineers who have spent careers at the intersection of quantitative pharmacology and clinical care. The science is never far from the work.

We started InsightRX because the technology to truly individualize drug therapy already existed in research labs. What was missing was a way to put it directly in the hands of the pharmacists and physicians making those decisions every day.

- Sirj Goswami PhD

Co-Founder & Chief Executive Officer

Our Mission

Our mission defines the clinical and scientific problem we exist to solve — and the standard every product decision is held to.

We build products that maximize therapeutic success through treatment individualization and population-level analysis.

Our Values

The principles behind our work.

These core principles guide how we work, collaborate, and innovate every day. They shape our culture and drive us toward our mission.

  

Forward-Looking

We are curious, bold, and challenge the status quo.
  

Intellectually Rigorous

Our scientific approach drives results.
  

Elevate Those Around Us

We collectively contribute using individual strengths.
  

Self-Directed Accountability

We honor our commitments and achieve results for our clients.
  

Engaged & Optimistic

Our work is fulfilling.

Our Team

When precision matters, so do the people.

InsightRX is guided by the people who understand the problem most deeply. Our leadership team brings together decades of experience in pharmacometrics, clinical pharmacy, and health IT. Our scientists and engineers have spent their careers at the intersection of quantitative science and software.

Our Advisory Board extends that depth — connecting our platform to the leading edge of academic and pharmaceutical research worldwide. Their expertise shapes how we construct, validate, and refine our models, and the science they produce is published, peer-reviewed, and openly shared with the field.

Our History

A decade of precision medicine.

Feb 2015

InsightRX founded

Founded in San Francisco by three pharmacometricians with a mission to bring model-informed precision dosing into clinical practice.

Jul 2016

First partnership signed

The first commercial partnerships validated the hypothesis that model-informed precision dosing can deliver significant value to clinical teams.

Jan 2018

Nova launched

First clinical deployment of InsightRX Nova, bringing Bayesian MIPD to pharmacy teams at academic medical centers

Oct 2019

$10M Series A

Raised $10M to broaden therapeutic coverage and expand access to precision dosing for hospitals and pharmaceutical companies.

Nov 2019

Apollo launched

InsightRX Apollo introduced real-time analytics and population-level reporting for pharmacy program directors.

Nov 2020

CE mark received

CE mark certification received, confirming conformance with EU health, safety, and data protection requirements and opening clinical deployment across the European Union.

Mar 2024

1 million patients dosed

InsightRX precision dosing platforms crossed one million patients treated, reflecting broad clinical adoption across health systems worldwide.

Aug 2024

Gemini launched

InsightRX Gemini launched, bringing automated vancomycin PK model selection to pharmacists via an algorithm built on more than 300,000 treatment courses.

Dec 2025

1,000 hospitals

InsightRX surpassed 1,000 hospital partners, establishing the platform as one of the most widely adopted precision dosing solutions in the world.

May 2026

Astra launched

Astra launched, bringing conversational PK/PD analysis and end-to-end workflow automation to life sciences, researchers, scientists, and pharmacometricians.

Our Vision

A future where every approved medication works as intended.

We aspire to build a future where patients and healthcare stakeholders can be confident that all approved medications will work as intended, with minimal side effects.

How we're moving beyond static decision support with AI-powered precision medicine

General-purpose AI systems are fluent and fast, but clinical decision-making demands more than plausible answers. InsightRX engineers AI grounded in pharmacokinetic science, real patient data, and evidence-based protocols.

Our customers

Trusted where it matters most.

From community hospitals to academic medical centers, pharmacists and clinical teams rely on InsightRX to advance safe and effective drug therapy and ensure every patient receives a dose that is right for them.

1,000+
hospitals and health systems trust InsightRX
1.9M+
patients impacted by precision dosing
5.6M+
doses personalized using InsightRX

Careers

United by a shared belief in the vision of precision medicine.

The tools clinicians trust are only as good as the people who build them.